Ablan Sherimay, Rawat Satinder S, Viard Mathias, Wang Ji Ming, Puri Anu, Blumenthal Robert
Center for Cancer Research Nanobiology Program, Center for Cancer Research, National Cancer Insitute, National Institutes of Health, Frederick, Maryland, USA.
Virol J. 2006 Dec 22;3:104. doi: 10.1186/1743-422X-3-104.
HIV-1 entry into cells is a multifaceted process involving target cell CD4 and the chemokine receptors, CXCR4 or CCR5. The lipid composition of the host cell plays a significant role in the HIV fusion process as it orchestrates the appropriate disposition of CD4 and co-receptors required for HIV-1 envelope glycoprotein (Env)-mediated fusion. The cell membrane is primarily composed of sphingolipids and cholesterol. The effects of lipid modulation on CD4 disposition in the membrane and their role in HIV-1 entry have extensively been studied. To focus on the role of lipid composition on chemokine receptor function, we have by-passed the CD4 requirement for HIV-1 Env-mediated fusion by using a CD4-independent strain of HIV-1 Env.
Cell fusion mediated by a CD4-independent strain of HIV-1 Env was monitored by observing dye transfer between Env-expressing cells and NIH3T3 cells bearing CXCR4 or CCR5 in the presence or absence of CD4. Chemokine receptor signaling was assessed by monitoring changes in intracellular [Ca2+] mobilization induced by CCR5 or CXCR4 ligand. To modulate target membrane cholesterol or sphingolipids we used Methyl-beta-cyclodextrin (MbetaCD) or 1-phenyl-2-hexadecanoylamino-3-morpholino-1-propanol (PPMP), respectively. Treatment of the target cells with these agents did not change the levels of CD4 or CXCR4, but reduced levels of CCR5 on the cell surface. Chemokine receptor signalling was inhibited by cholesterol removal but not by treatment with PPMP. HIV-1 Env mediated fusion was inhibited by >50% by cholesterol removal. Overall, PPMP treatment appeared to slow down the rates of CD4-independent HIV-1 Env-mediated Fusion. However, in the case of CXCR4-dependent fusion, the differences between untreated and PPMP-treated cells did not appear to be significant.
Although modulation of cholesterol and sphingolipids has similar effects on CD4-dependent HIV-1 Env-mediated fusion, sphingolipid modulation had little effect on CD4-independent HIV-1 Env-mediated fusion. Chemokine receptor function remained intact following treatment of cells with PPMP. Therefore such treatment may be considered a more suitable agent to inhibit CD4 dependent HIV-1 infection.
HIV-1进入细胞是一个多方面的过程,涉及靶细胞CD4以及趋化因子受体CXCR4或CCR5。宿主细胞的脂质组成在HIV融合过程中起着重要作用,因为它协调了HIV-1包膜糖蛋白(Env)介导融合所需的CD4和共受体的适当分布。细胞膜主要由鞘脂和胆固醇组成。脂质调节对膜中CD4分布的影响及其在HIV-1进入中的作用已得到广泛研究。为了关注脂质组成对趋化因子受体功能的作用,我们通过使用一种不依赖CD4的HIV-1 Env毒株绕过了HIV-1 Env介导融合对CD4的需求。
在有或没有CD4的情况下,通过观察表达Env的细胞与携带CXCR4或CCR5的NIH3T3细胞之间的染料转移,监测由不依赖CD4的HIV-1 Env毒株介导的细胞融合。通过监测CCR5或CXCR4配体诱导的细胞内[Ca2+]动员变化来评估趋化因子受体信号传导。为了调节靶膜胆固醇或鞘脂,我们分别使用了甲基-β-环糊精(MβCD)或1-苯基-2-十六烷酰氨基-3-吗啉代-1-丙醇(PPMP)。用这些试剂处理靶细胞不会改变CD4或CXCR4的水平,但会降低细胞表面CCR5的水平。胆固醇去除会抑制趋化因子受体信号传导,但PPMP处理则不会。胆固醇去除会使HIV-1 Env介导的融合受到>50%的抑制。总体而言,PPMP处理似乎减缓了不依赖CD4的HIV-1 Env介导融合的速率。然而,在依赖CXCR4的融合情况下,未处理细胞与PPMP处理细胞之间的差异似乎并不显著。
尽管胆固醇和鞘脂的调节对依赖CD4的HIV-1 Env介导融合有相似的影响,但鞘脂调节对不依赖CD4的HIV-1 Env介导融合影响很小。用PPMP处理细胞后,趋化因子受体功能保持完整。因此,这种处理可能被认为是一种更适合抑制依赖CD4的HIV-1感染的试剂。